Companies in 940
| Company | Sector & Purpose | Updated | Following |
|---|---|---|---|
|
Confluent
|
Data Streaming
Set data in motion with a cloud-native data streaming platform built for real-time innovation
|
2025-Q3
|
|
|
Accuray
|
Medical Device Technology
To expand the powerful potential of radiation therapy to improve as many lives as possible
|
2025-Q3
|
|
|
Alphabet
|
Technology
Organize the world's information and make it universally accessible and useful
|
2025-Q3
|
|
|
C3.Ai
|
Enterprise AI Software
To accelerate digital transformation with enterprise AI applications
|
2025-Q3
|
|
|
Addepar
|
WealthTech
To make the financial world more transparent, efficient, and accessible for all
|
2025-Q3
|
|
|
Alpha And Omega Semiconductor
|
Power Semiconductors
To deliver innovative power management solutions for efficient energy conversion
|
2025-Q3
|
|
|
Alector
|
Biotechnology
To develop innovative immunotherapies for neurodegenerative diseases by harnessing the brain's immune system
|
2025-Q3
|
|
|
Allogene Therapeutics
|
Biotechnology
To develop transformative allogeneic CAR T cell therapies to treat cancer patients
|
2025-Q3
|
|
|
Ceva
|
Semiconductor IP
To enable smarter, connected devices through innovative semiconductor IP and software platforms for AI, 5G, and IoT applications
|
2025-Q3
|
|
|
Aeva Technologies
|
Automotive Technology
To develop 4D LiDAR sensing technology that enables the next generation of autonomous machines to perceive and interact with the world safely
|
2025-Q3
|
|
|
Box
|
Cloud Content Management
To transform how the world works together through secure cloud content management
|
2025-Q3
|
|
|
Applied Intuition
|
Autonomous Vehicle Software
To accelerate the safe deployment of autonomous vehicles through advanced simulation and validation tools
|
2025-Q3
|
|
|
Annexon
|
Biotechnology
To develop innovative complement-targeted therapeutics for patients with classical complement-mediated autoimmune and neurodegenerative diseases
|
2025-Q3
|
|
|
Alation
|
Data Intelligence
To democratize data literacy and enable organizations to unlock the full potential of their data through intelligent data cataloging and governance solutions.
|
2025-Q3
|
|
|
Akero Therapeutics
|
Biotechnology
To develop and commercialize transformational treatments for patients with serious metabolic diseases
|
2025-Q3
|
|
|
Alumis
|
Biotechnology
To develop transformative medicines for autoimmune and inflammatory diseases through precision targeting of key immune pathways
|
2025-Q3
|
|
|
Apogee Therapeutics
|
Biotechnology
To develop transformative immunology medicines for patients with serious diseases
|
2025-Q3
|
Page 1 of 3
Showing 1 to 20 of 47 analyses